Jazz Pharmaceuticals, Inc.’s working capital deficit rose 39.8%, or US$8.9 million, from US$22.3 million at December 31, 2009, to US$31.2 million at March 31, 2010.
The Company reported current assets of…
At December 31, 2009, Dragon Pharmaceutical Inc. had current liabilities of US$109.37 million and current assets of US$55.92 million, including cash and restricted cash of US$7.97 million and accounts receivable…
Synovics Pharmaceuticals, Inc.,’s working capital deficit rose by 63.2%, from US$6,335,161 at Oct. 31, 2008 to US$10.337.159 at April 30, 2009.
The Company reported US$5,134,320 in current assets and US$15,471,479 in…
American Shared Hospital Services’ working capital deficit rose by 275%, or US$564,000, from US$205,000 at Dec. 31, 2008 to US$769,000 at March 31, 2009.
The Company reported US$14.88 million in current…
Genmed Holding Corp.’s working capital deficit rose by 97%, or US$913,669, from US$940,796 at Dec. 31, 2007 to US$1,854,465 at Dec. 31, 2008.
The Company reported US$10,541 in current assets and…
Express Scripts, Inc. reported a working capital deficit of US$677.90 million at Dec. 31, 2008, a 34% increase from US$507.20 million at Dec. 31, 2007.
The Company had US$2.043 billion in…
Oscient Pharmaceuticals Corporation reported a working capital deficit of US$11.37 million at Sept. 30, 2008, according to its Registration Statement filed on Form S-1 with the U.S. Securities and Exchange…
GeoPharma, Inc. reported a working capital deficit of US$3.82 million at Dec. 31, 2008, compared to a positive working capital of US$1.15 million at March 31, 2008.
The Company had US$21.83…
Shengtai Pharmaceutical, Inc.’s working capital deficit dropped by 16%, from US$27.62 million at June 30, 2008 to US$23.04 million at Dec. 31, 2008.
The Company had US$27.70 million in current assets…
Synovics Pharmaceuticals, Inc.’s working capital deficit dropped by 67%, or US$13.12 million, from US$19.45 million at Oct. 31, 2007 to US$6.33 million at Oct. 31, 2008.
The Company reported US$7.16 million…